Suppr超能文献

在一致性非人灵长类动物模型中的耐受性。

Tolerance in a concordant nonhuman primate model.

作者信息

Bartholomew A M, Powelson J, Sachs D H, Bailin M, Boskovic S, Colvin R, Hong H Z, Johnson M, Kimikawa M, LeGuern A, Meehan S, Sablinski T, Wee S L, Cosimi A B

机构信息

Transplantation Unit of the General Surgical Service, Massachusetts General Hospital, Department of Surgery, Harvard Medical School, Boston 02114, USA.

出版信息

Transplantation. 1999 Dec 15;68(11):1708-16. doi: 10.1097/00007890-199912150-00014.

Abstract

BACKGROUND

We have previously demonstrated that induction of mixed lymphohematopoietic chimerism resulted in donor specific renal allograft tolerance without the need for chronic immunosuppression in nonhuman primates. Here we have tested whether tolerance can be similarly induced for baboon to cynomolgus renal xenografts.

METHODS

After preconditioning with anti-thymocyte globulin (ATG), nonlethal total body irradiation, and thymic irradiation, cynomolgus monkeys underwent splenectomy, native nephrectomies, and baboon marrow and renal transplants. Postoperative cyclosporine was given for 28 days.

RESULTS

In Group 1 (n=2, survival= 13, 14 days), both animals developed anti-donor immunoglobulin G, had biopsy findings consistent with humoral rejection, and showed rapidly progressive xenograft failure. In Group 2 (n=5, survival=1, 16, 33, 112, 190 days), 15-deoxyspergualine was added to the regimen (Day 0-13). In one long-term survivor, donor specific hyporesponsiveness was first observed (mixed lymphocyte culture [(MLR]) on Day 48. MLR reactivity returned on Day 64 together with the development of anti-donor antibody and subsequent xenograft failure on Day 112. Donor specific T-cell hyporesponsiveness was detected in the other long-term survivor for the first 133 days, after which a donor-specific skin xenograft was placed, (survival 24 days). Following the skin graft rejection, a rise in the MLR, development of anti-donor antibody and progressive rejection of the renal xenograft were observed.

CONCLUSIONS

Antibody-mediated rejection seems to constitute the major difference between concordant xenografts and allografts. Addition of 15-deoxyspergualine for 2 weeks posttransplant extended concordant primate xenograft survival to 6 months without chronic immunosuppression. In contrast to the allogeneic model, renal transplant acceptance in this xenogeneic system was interrupted by placement of a donor-specific skin graft.

摘要

背景

我们之前已经证明,在非人灵长类动物中诱导混合淋巴细胞造血嵌合体可导致供体特异性肾移植耐受,而无需长期免疫抑制。在此,我们测试了狒狒对食蟹猴肾异种移植是否能类似地诱导出耐受。

方法

在用抗胸腺细胞球蛋白(ATG)、非致死性全身照射和胸腺照射进行预处理后,食蟹猴接受脾切除术、原位肾切除术以及狒狒骨髓和肾移植。术后给予环孢素28天。

结果

在第1组(n = 2,存活时间分别为13天、14天)中,两只动物均产生了抗供体免疫球蛋白G,活检结果符合体液排斥反应,并显示出快速进展的异种移植失败。在第2组(n = 5,存活时间分别为1天、16天、33天、112天、190天)中,在方案中加入了15 - 去氧精胍菌素(第0 - 13天)。在一名长期存活者中,首次在第48天观察到供体特异性低反应性(混合淋巴细胞培养[MLR])。MLR反应性在第64天恢复,同时出现抗供体抗体,并在第112天出现随后的异种移植失败。在另一名长期存活者中,在最初的133天检测到供体特异性T细胞低反应性,之后进行了供体特异性皮肤异种移植(存活24天)。在皮肤移植排斥后,观察到MLR升高、抗供体抗体产生以及肾异种移植的进行性排斥。

结论

抗体介导的排斥似乎是协调性异种移植和同种异体移植之间的主要差异。移植后添加15 - 去氧精胍菌素2周可使协调性灵长类异种移植存活期延长至6个月,而无需长期免疫抑制。与同种异体模型不同,在这个异种系统中肾移植的接受被供体特异性皮肤移植所中断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验